KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to -$26.9 million.

  • Evolent Health's Net Income towards Common Stockholders rose 1377.16% to -$26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$180.9 million, marking a year-over-year decrease of 7353.74%. This contributed to the annual value of -$93.5 million for FY2024, which is 3430.76% up from last year.
  • Latest data reveals that Evolent Health reported Net Income towards Common Stockholders of -$26.9 million as of Q3 2025, which was up 1377.16% from -$51.1 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Net Income towards Common Stockholders ranged from a high of $2.1 million in Q3 2022 and a low of -$72.2 million during Q1 2025
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$25.2 million (2024), whereas its average is -$23.3 million.
  • Per our database at Business Quant, Evolent Health's Net Income towards Common Stockholders soared by 11628.07% in 2022 and then crashed by 166363.64% in 2023.
  • Quarter analysis of 5 years shows Evolent Health's Net Income towards Common Stockholders stood at -$5.6 million in 2021, then plummeted by 100.97% to -$11.3 million in 2022, then crashed by 264.75% to -$41.4 million in 2023, then rose by 26.04% to -$30.6 million in 2024, then rose by 12.04% to -$26.9 million in 2025.
  • Its last three reported values are -$26.9 million in Q3 2025, -$51.1 million for Q2 2025, and -$72.2 million during Q1 2025.